Evaluation allows for continuous improvement and sharing of best practices across the network. For Endo-ERN members there is self-evaluation annually, and an external review as part of the AMEQUIS cycle, every 5 years.

Objectives: Ensure consistent care for patients with rare endocrine
conditions within and without the Endo-ERN network. 

The representatives for WP3 Evaluation are:

prof. Alberto Pereira
Alberto Pereira

Alberto Pereira Adult chair

Amsterdam UMC (Amsterdam, Netherlands)
Johan de Graaf
Johan de Graaf

Johan de Graaf ePAG representative

Dutch Pituitary Foundation (Nijkerk, Netherlands)


Contact form


You can contact the representatives of WP3 “Evaluation” directly via email at evaluation@endo-ern.eu or use the contact form below.

    Fields marked with a * are required.

    Information video for patients and healthcare professionals

    Type and Press “enter” to Search